
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
New York -The old idea that chemical peels cannot be used on people of ethnic skin has been eradicated according to Harold E. Pierce, M.D., a Philadelphia dermatologist.